As healthcare professionals, it is crucial to understand the complexities of Parkinson's Disease (PD), a neurodegenerative disorder that has far-reaching implications on the quality of life of patients.
PD is primarily characterized by the degeneration of dopaminergic neurons in the substantia nigra, leading to a dopamine deficit in the striatum. While the exact cause remains unknown, both genetic and environmental factors are believed to play a role.
PD presents with motor symptoms such as bradykinesia, rigidity, and resting tremor. Non-motor symptoms, including cognitive impairment, mood disorders, and autonomic dysfunction, may precede motor symptoms and significantly impact a patient's life.
Diagnosis of PD is primarily clinical, based on the presence of cardinal motor symptoms and response to dopaminergic therapy. Neuroimaging techniques can provide supportive evidence but are not diagnostic.
Management of PD is symptomatic, focusing on improving quality of life. Pharmacological treatment principally involves dopamine replacement or mimicking its effects. Non-pharmacological interventions include physical therapy and deep brain stimulation.
PD is a progressive disease with no cure. However, advancements in research are promising, with ongoing studies exploring neuroprotective strategies and disease-modifying therapies.
Understanding PD's complexity is key to providing comprehensive care to patients. As healthcare professionals, we must stay updated on the latest research developments to improve patient outcomes. Continued focus on patient-centered care, encompassing not just the motor symptoms but also the non-motor manifestations of PD, will ensure a holistic approach to management.
1.
Global warming could be driving up women's cancer risk, find researchers
2.
Blood tests can predict the risk of relapse after a bone marrow transplant in patients with acute myeloid leukemia.
3.
Survey shows cancer anxiety has impact well beyond the individual diagnosed
4.
MRI can save rectal cancer patients from surgery, study suggests
5.
Glioma Outcomes Shaped by Subtype More Than Tx Sequence
1.
Rehabilitation After Organ-Conserving Cancer Surgery
2.
Practical Breakthroughs in Oncology Across Clinical Settings
3.
Gynecologic Oncology: Advances, Education, and Clinical Excellence
4.
Breaking Down the Different Types of Lymphoma: What You Need to Know
5.
RNA-Targeting Chimeras in Cancer: Mechanisms, Clinical Advances, and Future Directions
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
Cancer Care: From Awareness to Recovery
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
5.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation